openPR Logo
Press release

Global Liposome Drug Delivery Market

11-14-2018 02:06 PM CET | Health & Medicine

Press release from: Amecoresearch.com

The “Global Liposome Drug Delivery Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Liposome Drug Delivery Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Global Liposome Drug Delivery Market discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/9145

This report studies the global market size of Liposome Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liposome Drug Delivery in these regions.

This research report categorizes the global Liposome Drug Delivery market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Liposome Drug Delivery include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Liposome Drug Delivery include
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia

View Detail Report With Complete Table of Content@ http://www.amecoresearch.com/market-report/global-liposome-drug-delivery-market-insights-forecast-to-2025-9145

Market Size Split by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Market Size Split by Application
Cancer & Tumor Therapy
Fungal Infection Therapy
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

Table of Contents

Global Liposome Drug Delivery Market Insights, Forecast to 2025

1 Study Coverage
1.1 Liposome Drug Delivery Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Liposome Drug Delivery Market Size Growth Rate by Type
1.4.2 Liposomal Doxorubicin
1.4.3 Liposomal Amphoteracin B
1.4.4 Liposomal Paclitaxel
1.4.5 Others
1.5 Market by Application
1.5.1 Global Liposome Drug Delivery Market Size Growth Rate by Application
1.5.2 Cancer & Tumor Therapy
1.5.3 Fungal Infection Therapy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Liposome Drug Delivery Market Size
2.1.1 Global Liposome Drug Delivery Revenue 2016-2025
2.1.2 Global Liposome Drug Delivery Sales 2016-2025
2.2 Liposome Drug Delivery Growth Rate by Regions
2.2.1 Global Liposome Drug Delivery Sales by Regions
2.2.2 Global Liposome Drug Delivery Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Liposome Drug Delivery Sales by Manufacturers
3.1.1 Liposome Drug Delivery Sales by Manufacturers
3.1.2 Liposome Drug Delivery Sales Market Share by Manufacturers
3.1.3 Global Liposome Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2 Liposome Drug Delivery Revenue by Manufacturers
3.2.1 Liposome Drug Delivery Revenue by Manufacturers (2016-2018)
3.2.2 Liposome Drug Delivery Revenue Share by Manufacturers (2016-2018)
3.3 Liposome Drug Delivery Price by Manufacturers
3.4 Liposome Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Liposome Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liposome Drug Delivery Product Category
3.4.3 Date of International Manufacturers Enter into Liposome Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Liposome Drug Delivery Sales by Type
4.2 Global Liposome Drug Delivery Revenue by Type
4.3 Liposome Drug Delivery Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Liposome Drug Delivery Breakdown Data by Application

6 North America
6.1 North America Liposome Drug Delivery by Countries
6.1.1 North America Liposome Drug Delivery Sales by Countries
6.1.2 North America Liposome Drug Delivery Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Liposome Drug Delivery by Type
6.3 North America Liposome Drug Delivery by Application
6.4 North America Liposome Drug Delivery by Company

7 Europe
7.1 Europe Liposome Drug Delivery by Countries
7.1.1 Europe Liposome Drug Delivery Sales by Countries
7.1.2 Europe Liposome Drug Delivery Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Liposome Drug Delivery by Type
7.3 Europe Liposome Drug Delivery by Application
7.4 Europe Liposome Drug Delivery by Company

8 Asia Pacific
8.1 Asia Pacific Liposome Drug Delivery by Countries
8.1.1 Asia Pacific Liposome Drug Delivery Sales by Countries
8.1.2 Asia Pacific Liposome Drug Delivery Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Liposome Drug Delivery by Type
8.3 Asia Pacific Liposome Drug Delivery by Application
8.4 Asia Pacific Liposome Drug Delivery by Company

9 Central & South America
9.1 Central & South America Liposome Drug Delivery by Countries
9.1.1 Central & South America Liposome Drug Delivery Sales by Countries
9.1.2 Central & South America Liposome Drug Delivery Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Liposome Drug Delivery by Type
9.3 Central & South America Liposome Drug Delivery by Application
9.4 Central & South America Liposome Drug Delivery by Company

10 Middle East and Africa
10.1 Middle East and Africa Liposome Drug Delivery by Countries
10.1.1 Middle East and Africa Liposome Drug Delivery Sales by Countries
10.1.2 Middle East and Africa Liposome Drug Delivery Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Liposome Drug Delivery by Type
10.3 Middle East and Africa Liposome Drug Delivery by Application
10.4 Middle East and Africa Liposome Drug Delivery by Company

11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.1.4 Liposome Drug Delivery Product Description
11.1.5 Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.2.4 Liposome Drug Delivery Product Description
11.2.5 Recent Development
11.3 Pacira
11.3.1 Pacira Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.3.4 Liposome Drug Delivery Product Description
11.3.5 Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.4.4 Liposome Drug Delivery Product Description
11.4.5 Recent Development
11.5 Luye Pharma
11.5.1 Luye Pharma Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.5.4 Liposome Drug Delivery Product Description
11.5.5 Recent Development
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.6.4 Liposome Drug Delivery Product Description
11.6.5 Recent Development
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.7.4 Liposome Drug Delivery Product Description
11.7.5 Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.8.4 Liposome Drug Delivery Product Description
11.8.5 Recent Development
11.9 CSPC
11.9.1 CSPC Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.9.4 Liposome Drug Delivery Product Description
11.9.5 Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Liposome Drug Delivery
11.10.4 Liposome Drug Delivery Product Description
11.10.5 Recent Development
11.11 Kingond Pharm
11.12 Spectrum Pharmaceuticals
11.13 Shanghai New Asia

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Liposome Drug Delivery Raw Material
13.1.2 Liposome Drug Delivery Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/9145

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Call: + 1 407 915 4157 | Email: sales@amecoresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Liposome Drug Delivery Market here

News-ID: 1370083 • Views: 174

More Releases from Amecoresearch.com

Global Coconut Shell Activated Carbon Market Analysis,Geographical Segmentation, …
The “Global Coconut Shell Activated Carbon Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Coconut Shell Activated Carbon Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players
Global Smart Windows Market Size 2018 - 2025: Industry Share, Trends and Forecas …
The “Global Smart Windows Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Smart Windows Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company
Global Tert-Butylhydroquinone Market Size, Growth, Trends, Demand, Segment Analy …
The “Global Tert-Butylhydroquinone Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Tert-Butylhydroquinone Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company profiles, product
Global FVMQ Rubber Market Forecast 2018-2025 on Market Dynamics, Emerging Trends …
The “Global FVMQ Rubber Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global FVMQ Rubber Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company

All 5 Releases


More Releases for Liposome

Injectable Nanomedicines Market Poised to Witness Strong Revenue Growth, as Lipo …
The growth of the injectable nanomedicines market is attributed to the growing use of liposomal drugs and increase in treatment seeking population across the globe. According to a latest research by the company, the global liposomes market is expected to account for revenues over US$ 300 Mn in terms of value by 2026 end. Injectable nanomedicines market is expected to witness significant growth with CAGR pegged at 8.1% through 2026.
Global Nanoemulsion Market 2018: Covaris, Inc, LATITUDE Pharmaceuticals Inc., Ta …
Small size and high advantages of nanoemulsion allow for multiple applications in pharmaceuticals, creating significant growth opportunity for pharma companies. Nanoemulsions allow for small and slow administration of oral drugs and assure the complete absorption of drugs and reduce dose related toxicity. Various studies have been carried out to explore other avenues of drug delivery using nanoemulsion. In 2009, a study conducted in National Research Center, Dokki, Cairo, Egypt concluded
Liposome in Cosmetics Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Liposome in Cosmetics market. Liposomes are spherical vesicles in which their central aqueous section is surrounded by one or more of a bilayer membrane (Lamella) that is frequently enclosed by aquatic environments. These vesicles are formed when amphiphilic lipids confront with aqueous milieu. They can vary in size from 15 nm to several microns. In the
Liposome in Cosmetics Industry Analysis by 2025:  QY Research
In its recently published report, QY Research has provided unique insights about global Liposome in Cosmetics market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global Liposome in Cosmetics market. The scope of
Rectal Cancer Therapeutics Pipeline Review 2018 - Taiwan Liposome Company, Sanof …
According to the research findings, most of the drug candidates for the treatment of rectal cancer are being developed to be administered by the intravenous and the oral route. The main advantage associated with the intravenous route is that the drug can easily be entered the bloodstream, or lymph vessels. Also, medication can be easy to take through the oral route, additionally the route has very less patient non-compliance. Browse report
New Report Examines the Liposome Drug Delivery Market
Liposomes are small spherical-shaped artificial vesicles synthesized from phospholipids and cholesterol. They are colloidal carriers and range from 0.01 to 5.0 μm in diameter. These are lipid bilayer vesicles having hydrophilic and hydrophobic properties. Due to these properties liposomes have an advantage of encapsulating hydrophobic as well as hydrophilic drugs and delivering them to the targeted site in the body. Thus, liposomes are promising systems for targeted drug delivery.